Kerala Ayurveda reports FY25 consolidated revenue higher by 22% at Rs. 137.2 Cr
News

Kerala Ayurveda reports FY25 consolidated revenue higher by 22% at Rs. 137.2 Cr

Adjusted EBITDA positive at Rs. 3.1 crore despite investments in marketing, talent hiring and technology over the year

  • By IPP Bureau | May 28, 2025

Kerala Ayurveda Limited (KAL) consolidated FY25 revenue grew by a strong 22% (17.4% excluding Ayurvedagram Bali + Om Vedic Singapore) vs. year ago. This reflects the continued strong growth in the US business driven by the Academy business (52% growth) and US Wellness Center (47%) and strong growth in the Ayurvedagram Bali business (71%) behind increased occupancy. The India Ecommerce business saw a continued upswing in growth with Q4’25 growing at 37% vs. year ago.

Consolidated FY’25 PAT of Rs. -13.95 crore (vs Rs. -56 Lakhs FY’24) is due to deliberate investments in building the foundation for a long term, sustainable business. The focus was on building a strong leadership team, creating the right infrastructure – plant, tech, resorts (Rs.6 crore Capex), building talent (Rs. 13.5 crore.) and investing in digital marketing (Rs.6 crore). There was also a focused effort on driving greater operational discipline around cash flows - inventory, credit limits, bad debts provisioning and improving the standards of customer experience behind clinical excellence at our clinics leading to some business transition impact. There was also an impact of provisioning for ESOPs (Rs.6.2 crore.) which was being done for the first time.

Other Related stories

Startup

Digitization

India is becoming centre of innovation and global execution: Sanjay Vyas, President and MD, Parexel India
India is becoming centre of innovation and global execution: Sanjay Vyas, President and MD, Parexel India
Sanjay Vyas President and Managing Director, Parexel India And Global SBU Head- Safety services & Logistics, Parexel International